Acetylcysteine is a topic covered in the Johns Hopkins Diabetes Guide.
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
INDICATIONS
FDA
FDA
- Adjuvant mucolytic therapy for patients with abnormal, viscid, or inspissated mucous secretions secondary to respiratory diseases such as emphysema, tuberculosis, bronchitis or for treatment of respiratory complications of cystic fibrosis and tracheostomy care.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
- Nephrotoxicity prophylaxis (focus of this module)
- Acetaminophen overdose
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: January 6, 2016
Citation
* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Acetylcysteine
ID - 547001
A1 - Crowder,Alona,Pharm.D.
AU - Samal,Lipika,M.D.
Y1 - 2016/01/06/
PB - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547001/all/Acetylcysteine
ER -